Advertisement

Pfizer Recalls All Lots of Chantix Due to Potential Carcinogen

0

0.5-mg and 1-mg tablets may contain levels of N-nitroso-varenicline at or above levels approved by the FDA

FDA Advisory Panel to Hold Meeting Today on COVID-19 Booster Shots

0

Advisory panel will review a variety of evidence, including new data from Israel

Most Highly Allergic People Can Be Safely Immunized Against COVID-19

0

Algorithm enables immunization of most individuals, with 0.7 percent developing anaphylactic reaction after one BNT162b2 dose

Individuals With COVID-19 Most Infectious Around Symptom Onset

0

Individuals are most infectious in the two days before and three days after symptom onset

Maternal Mortality in the U.S. Higher Among Black Women

0

Postpartum cardiomyopathy, preeclampsia, and eclampsia are leading causes of maternal death for Black women

Risk for Asthma at Age 4 Years Higher After Pneumonia in Infancy

0

Risk slightly higher after introduction of nationwide pneumococcal conjugate vaccine

Substance Use Disorder Prevalent for Young Adults With ADHD

0

Odds increased for developing alcohol use disorders, cannabis use disorders, other drug use disorders

Outcome Good at One Year for Majority of PIMS-TS Patients

0

Patients presenting with impaired cardiac function without aneurysm on echocardiography had all recovered by day 74

CDC Recommendations for Influenza Vaccination Updated for 2021-2022

0

ACIP makes no preferential recommendation when more than one licensed, recommended vaccine is available

Bystander Rescue Breathing CPR Beneficial for Pediatric OHCA

0

Odds of neurologically favorable survival improved for RB-CPR versus compression-only CPR